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Inversions are one type of structural variants linked to phenotypic differences and adaptation
in multiple organisms. However, there is still very little information about polymorphic
inversions in the human genome due to the difficulty of their detection. Here, we develop a
new high-throughput genotyping method based on probe hybridization and amplification, and
we perform a complete study of 45 common human inversions of 0.1–415 kb. Most inversions
promoted by homologous recombination occur recurrently in humans and great apes and
they are not tagged by SNPs. Furthermore, there is an enrichment of inversions showing
signatures of positive or balancing selection, diverse functional effects, such as gene dis-
ruption and gene-expression changes, or association with phenotypic traits. Therefore, our
results indicate that the genome is more dynamic than previously thought and that human
inversions have important functional and evolutionary consequences, making possible to
determine for the first time their contribution to complex traits.
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In the last decade a great effort has been devoted to char-acterizing all the variation in the human genome1–5, whichopens the door to determining the genetic basis of phenotypic
traits and disease susceptibility. Nevertheless, despite the initial
expectations, a significant fraction of the genetic risk for common
and complex diseases is still unexplained6,7. Furthermore, not all
variants have been studied at the same level of detail. In parti-
cular, inversions are a type of structural variant that changes the
orientation of a genomic segment, usually without gain or loss of
DNA, and they often have highly-identical inverted repeats (IRs)
at their breakpoints. These characteristics make inversion detec-
tion very challenging, even with next-generation sequencing
methods, and they have been largely overlooked in humans8,9.
Genome-wide inversion discovery has been typically based
on genome sequence comparison10,11 or paired-end mapping
(PEM)4,12, although recent studies have exploited newer techni-
ques that could be especially useful for inversion detection, such
as long-read sequencing13–15, Strand-seq16, BioNano optical
maps17, or a combination of them18. In most cases around
100–200 inversions have been predicted, with a maximum of 786
predictions in the 1000 Genomes Project (1000GP)4,19. However,
these methods are not suitable for high-throughput genotyping,
and with few exceptions4,16,20, just a reduced number of indivi-
duals (1–15) have been analyzed. Moreover, the presence of
repetitive sequences at the breakpoints influences the inversions
that can be detected by each technique and results in high error
rates for inversion validation compared to other variants4,18,20,21.
Apart from the intensely-studied 17q21.31 and 8p23.1
inversions22,23, genotyping efforts have been restricted to a small
number of inversions and samples. For example, four other large
inversions have been genotyped by FISH24 and five smaller
inversions by PCR25 in 27 and 42 individuals of four populations,
respectively. In addition, PCR and inverse PCR (iPCR) have been
used for targeted studies of 34 inversions in 70–90 Europeans21,26
and a more worldwide characterization of three inversions25,27,28.
Also, although inversion genotypes might be predicted based on
SNP data, these methods can only detect inversions above a
certain size or associated with specific SNP combinations and the
error rate can be high21,23,25,29. Therefore, it is not yet clear how
many polymorphic inversions really exist in humans and very
little is known about their global frequency and distribution19.
Actually, inversions have been a model in evolutionary biology
for almost 90 years30,31 and there are numerous examples of their
phenotypic consequences and adaptive significance in diverse
organisms, from plants to birds32. One of their main effects is
related to recombination, since single crossovers within the
inverted region in heterozygotes generate unbalanced gametes
and, at the same time, the resulting inhibition of recombination
could protect favorable allele combinations30,31. In addition,
inversion breakpoints can directly alter the expression patterns of
adjacent genes9,33.
From the little information available, it is clear that inversions
can have important consequences in humans9. Inversions are
associated with haemophilia A34, increased risk of neurodegen-
erative diseases35–37, autoimmune diseases23,29 or mental dis-
orders38. They could also predispose to other genomic
rearrangements with negative phenotypic consequences in the
offspring9. Moreover, there is evidence that the 17q21.31 inver-
sion increases the fertility of the carriers and has been positively
selected in Europeans22. Finally, inversions have been shown to
affect gene expression23,28,29,39. However, most of these effects
are associated with just the two best-known inversions. Attempts
to associate inversions with gene-expression and phenotypic
variation in large datasets have been limited to those with simple
breakpoints, and only a couple of additional candidates have been
identified so far4,40,41. Thus, specific genotyping studies of a
diverse range of inversions in multiple individuals are necessary
to determine their functional and evolutionary impact.
Here, we have developed a new high-throughput genotyping
method and we have characterized in detail 45 common poly-
morphic inversions. By combining accurate inversion genotypes
in 551 individuals of different populations and the available
genomic information, we show that a large fraction of inversions
are not linked to other variants and have occurred recurrently. In
addition, several of them have signatures of selection and/or
functional effects, emphasizing the role of inversions in the
human genome.
Results
High-throughput genotyping of inversions. We focused on a
representative set of 45 paracentric inversions from the InvFEST
database19, which comprised most of those experimentally vali-
dated by PCR-based techniques when the project started19 and
corresponds approximately to half of the estimated number of
real variants with >5% frequency in human populations4,14
(Supplementary Fig. 1, Supplementary Data 1). These inversions
were originally detected in the comparison of the hg18 and HuRef
genome assemblies10 or a fosmid PEM survey in nine indivi-
duals12, and between 1 and 36 of them have been identified in
different recent studies (Supplementary Data 1). The main lim-
itation for inversion genotyping was due to breakpoint IRs, that
had to be of less than 25–30 kb and with target sites for certain
restriction enzymes at both sides but not within the IRs26, which
excluded previously-known large inversions mediated by big
repeat blocks19. Overall, the studied inversions are located
throughout the genome (37 in the autosomes, 7 in chr. X and 1 in
chr. Y), with sizes ranging from 83 bp to 415 kb. Also, 24 (53%)
have been generated by non-allelic homologous recombination
(NAHR) between >90% identical IRs (from 654 bp to 24.2 kb).
The rest (47%) were probably generated by non-homologous
mechanisms (NH), including 18 with small deletions or insertions
in the derived allele that may have been created in a single
complex FoSTeS/MMBIR event4,21 (Supplementary Fig. 1, Sup-
plementary Data 1).
Of those, 41 inversions were genotyped simultaneously using
high-throughput assays derived from the multiplex ligation-
dependent probe amplification (MLPA) technique42. For inver-
sions with simple breakpoint sequences (17), we carried out
directly custom MLPA assays with minor modifications. How-
ever, for inversions with repetitive sequences at the breakpoints
(24), which are difficult to detect by most techniques, we
developed a new method combining the principles of iPCR26 and
MLPA42 named iMLPA. In both cases, two pairs of oligonucleo-
tide probes were used to interrogate the two alternative
orientations for each inversion, orientation 1 (O1) and orienta-
tion 2 (O2) (Fig. 1). Four additional inversions not initially
included in the MLPA-like assays were tested independently by
PCR or iPCR (Supplementary Data 1). The 45 inversions were
genotyped in 551 individuals from seven populations studied in
HapMap and 1000GP1,3 with African (AFR) (YRI, LWK),
European (EUR) (CEU, TSI), South-Asian (SAS) (GIH) or
East-Asian (EAS) (CHB, JPT) ancestry, here referred as
population groups (Supplementary Table 1).
MLPA and iMLPA inversion genotypes were carefully
validated through several analyses and quality controls (Fig. 1):
(1) comparison with 3377 available genotypes19 (see Supplemen-
tary Data 1 for data source); (2) identification of potential iPCR
or iMLPA problems caused by restriction site polymorphisms;
and (3) association between inversions and other variants (see
below). As part of the validation, we repeated by PCR or iPCR
2160 extra genotypes with discrepancies or possible errors plus
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Fig. 1 Schematic representation of inversion genotyping strategy. High-throughput genotyping of the 45 inversions in 551 individuals from different
populations was done by MLPA (17), iMLPA (24), regular PCR (1) and iPCR (3). To avoid confusion about the ancestral status, the two inversion
orientations have been named as 1 (AB and CD breakpoints) and 2 (AC and BD breakpoints), using the hg18 genome assembly as reference
(Supplementary Data 1). In MLPA and iMLPA, two pairs of oligonucleotide probes (represented in top of the genome sequence) that are able to hybridize
contiguously to the target region through a specific sequence complementary to the genome (light grey) were used to interrogate the two alternative
orientations of each inversion. These probes, which include a stuffer sequence of variable length (black), are ligated together in a subsequent step and the
resulting products are amplified for all the analyzed inversions at the same time with common primers (in green). IRs or other repetitive sequences at the
breakpoints are represented as a dark pointed rectangle
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others randomly selected, including the whole set of 551
individuals for the three inversions that had the highest error
rate (HsInv0045, HsInv0055 and HsInv0340) (Supplementary
Data 1). This showed that the new inversion genotyping
technique is very robust, with missing data (0.7%) and genotype
errors for MLPA (0.1%) and iMLPA (0.9%) accumulating mainly
in specific problematic inversions or DNA samples (Supplemen-
tary Fig. 2A). When compared to the global inversion data from
the 1000GP4, just 14 of our inversions (31%) were detected, with
nine of them having 2.5–71.5% incorrect genotypes and
extremely low genotype agreement in the only two inversions
mediated by large IRs in common (Supplementary Fig. 2B).
Therefore, we have generated the largest and most accurate
dataset of different types of inversions in humans (Supplementary
Data 2).
As expected, the 45 inversions show correct genetic transmis-
sion in the 30 CEU and 30 YRI father-mother-child trios, and
allele frequencies do not deviate from Hardy-Weinberg equili-
brium in any population (P > 0.01). Minor allele frequencies
(MAF) range globally from 0.5% to 49.7%, with 41 inversions
spread through several population groups and only the four with
the lowest frequencies being present in a single population group
(HsInv0097, HsInv0284 and HsInv1051 in Africa; HsInv0379 in
East Asia) (Fig. 2; Supplementary Table 1). On average, an
African and non-African individual carry the O2 allele,
respectively, for 28 and 24 inversions.
Nucleotide variation and haplotype distribution. Thanks to the
accurate genotypes, we were able to explore the linkage dis-
equilibrium (LD) between inversions and neighboring variants
(SNPs and small indels) from HapMap and 1000GP1,3. While
most NH inversions (20/21) have variants in complete LD (r2=
1) either inside or up to 100 kb from the breakpoint, among the
24 NAHR inversions only HsInv0040 and HsInv1051 have at
least one such variant (Fig. 3a; Supplementary Table 2). Max-
imum r2 values between the remaining 22 NAHR inversions and
1000GP variants range from 0.14 to 0.91 (Fig. 3a).
Also, we checked the presence of shared SNPs (not including
indels) in both orientations. Consistent with recombination
inhibition in heterozygotes, most NH inversions do not have
shared SNPs within the inverted region in accessible 1000GP
positions or HapMap data, with the exception of a few
individual SNPs that might be genotype errors or gene
conversion events (Fig. 3a; Supplementary Table 2). Outside
of the inversion, the average proportion of shared 1000GP SNPs
increases progressively after the last fixed variant, up to ~20%
(Fig. 3b). This allowed us to define an extended area on each
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Fig. 2 Evolutionary and functional information for human polymorphic inversions. Frequency: inversion frequencies in the 480 unrelated individuals from
seven populations, showing either the derived allele frequency (DAF) if the ancestral orientation is known or the minor allele frequency (MAF) according to
the global frequency of the inversion otherwise (which enables the MAF to be higher than 0.5 in specific populations). Age: average age for 22 inversions in
which it can be calculated from the divergence between orientations using three different substitution rate estimates. Selection: summary of inversion
selection signatures from FST, LSFS (positive or balancing selection) and NCD1 and NCD2 tests. Populations where the signal was detected are indicated by
different colors in the corners of each cell, with alternating vertical and diagonal crosses to avoid visual overlap. Criteria for classification of strong and
weak selection evidence are explained in Supplementary Data 7. Function: functional effects of inversions summarizing direct gene mutations, which
include gene or transcript disruption (strong) or exchange of genic sequences (weak) (Supplementary Table 3), eQTLs in the GEUVADIS or GTEx datasets
(showing the number of affected genes and labeled as strong if inversion is lead eQTL for at least one gene) (Supplementary Data 8 and Supplementary
Data 9), and association with GWAS hits (strong if for one of the associations P < 1 × 10−6) (Supplementary Table 4) or GWAS signal enrichment (strong if
enrichment empirical test P < 0.01 in both GWAS databases). Source data are provided as a Source Data file
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side of the inversion of no or little recombination between
orientations, which ranges from 0 to more than 20 kb
(Supplementary Table 2). In contrast, 20 of the 24 NAHR
inversions have a considerable number of shared SNPs
scattered throughout the inverted and flanking regions (Fig. 3a,
b; Supplementary Table 2).
Next, we visualized the haplotype diversity and distribution
across orientations and populations using haplotype networks
and a new representation integrating a hierarchical clustering of
haplotypes and the differences between them (Supplementary
Fig. 3). This analysis was focused on 1000GP data, although
consistent results were obtained with HapMap SNPs. After taking
into account possible phasing errors, two clearly differentiated
patterns were observed again. In the 20 NH inversions with
sequence variation information, the haplotypes of one of the
orientations tend to cluster together, supporting a unique origin
of the inversion (Supplementary Fig. 3). In NAHR inversions, this
is true only for HsInv0040, HsInv0061 and HsInv1051, with the
other 21 having O1 and O2 haplotypes mixed throughout the
network and hierarchical cluster, including in many cases
identical haplotypes with both orientations (Supplementary
Fig. 3). Such pattern is consistent with a multiple origin of these
inversions and explains the absence of fixed SNPs and the high
number of shared SNPs between orientations.
Based on the results of the different analyses, we inferred the
minimum number of recurrent inversion events and their
distribution in human populations (Fig. 3a; Supplementary
Data 3). However, this relies on having differentiated haplotype
clusters in which the existence of the alternative orientation
cannot be easily explained by other factors (such as gene
conversion or genotype/phasing errors of a few variants). Another
problem is that recombination generates mixed sequences
between haplotype groups and makes it difficult to accurately
quantify recurrence. Thus, a nice example is chr. Y inversion
HsInv0832, in which there is no recombination. We used
available haplogroup information of 232 males from the known
chr. Y genealogical tree (Supplementary Data 4) to identify five
independent inversion events in the last ~60,000 years (Fig. 3c).
This results in an inversion rate of 5.35 × 10–5 per generation (see
Methods), which is ~1000 times higher than that of single bases.
For the inversions in which it is possible to quantify recurrence,
we estimated a total of 40 additional inversion and re-inversion
events (ranging for each inversion from 0 to 7 with an average of
2.2) (Supplementary Data 3). Of those, 12 are distributed globally
and could precede the out-of-Africa migration, 17 are restricted
to African individuals, and 11 probably appeared more recently in
non-African populations. The fact that many of the recurrence
events are shared by several individuals indicates that they are not
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et al77. For each chr. Y haplogroup, the number of males genotyped for HsInv0832 with each orientation is indicated in parenthesis (O1 in dark grey and O2
in red). Only the main branches and those including genotyped individuals are shown, with some characteristic mutations indicated in the tree. For
haplogroup E, one of the two possible scenarios is represented, with the alternative being two inversion events in E1a and E1b1a1 haplogroups. Source data
are provided as a Source Data file
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artifacts from lymphoblastoid cell line (LCL) culture. In addition,
as part of the validation of inversion genotypes, all the recurrence
events were confirmed by checking at least one of the supporting
individuals by PCR/iPCR. We have therefore extended consider-
ably the previous recurrence analysis of some of the inversions in
just the CEU population21,26.
Ancestral orientation and inversion age. The published data on
the ancestral orientation of 32 of the inversion regions21,26,28 was
complemented and expanded by experimentally testing 42
inversions for which the human or modified assays generated
reliable results in a panel of 23 chimpanzees (40 inversions) and
seven gorillas (41 inversions) (Supplementary Data 5). Inversion
orientation was also assessed in available genome assemblies of
both species plus orangutan and rhesus macaque (Supplementary
Data 6). In total, we could infer the ancestral allele for 29
inversions, with 15 showing the ancestral and 14 the derived allele
in the human reference genome. For the 21 NH inversions,
orientation was consistent in all the non-human samples and
genomes analyzed, and with existing deletions and insertions
occurring in the derived allele (Supplementary Data 1 and Sup-
plementary Data 6). In contrast, 14 of the 22 NAHR inversions
experimentally genotyped were polymorphic in at least one of
the apes (six in chimpanzees, two in gorillas and six in both
species) and several had opposite orientation in different primate
assemblies (Supplementary Data 6). This agrees with previous
analyses in a much smaller set of samples21,26, but we found
five additional polymorphic inversions in each species. In fact, the
lower number of polymorphic inversions in gorilla indicates that
more inversion regions might be identified as polymorphic in
non-human primates by analyzing more individuals. Given the
species divergence times, the most likely scenario is that shared
inversions have appeared independently in chimpanzee and
gorilla lineages, providing additional support for inversion
recurrence (Fig. 3a).
Moreover, we checked the presence of the breakpoint
sequences of 19 NH inversions without IRs in available
Neanderthal, Denisovan and two ancient modern human
genomes (Supplementary Data 6). Five inversions (HsInv0004,
HsInv0006, HsInv0201, HsInv0409, and HsInv1116) showed the
derived orientation in the Neanderthal or Denisovan genomes
(including two with the derived orientation in both). These
inversions are distributed through African and non-African
populations, which suggests that they are not the result of
introgression and they appeared before the divergence of the most
recent Homo groups, around 550,000–750,000 years ago (ya)43.
Finally, we dated more precisely 22 unique inversions from the
sequence divergence between orientations (Fig. 2; Supplementary
Data 6). Six inversions were estimated to have appeared more
than 1 Mya, including four with the derived orientation in
Neanderthal or Denisovan, plus HsInv0031 and HsInv0058. For
HsInv0006, the estimated age (407,795–495,470 ya) is slightly
more recent than the Neanderthal-Denisova and modern human
divergence, but it is very close to its lower bound. Ages of the rest
of inversions are consistent with their geographical distribution,
with inversions restricted to either African (HsInv0097 and
HsInv0284) or non-African populations (HsInv0379) having a
relatively recent origin. Only in two cosmopolitan inversions age
estimates are lower than population split times (HsInv1053 with a
negative age and HsInv0095 with 22,582–41,258 ya), probably
due to an underestimation of the divergence between orientations
caused by the limited sequence information available.
Analysis of inversion frequencies. To evaluate whether there are
selective pressures acting globally on inversions, we compared
the inversion frequency spectrum with that of SNPs sampled
according to neutral expectations (see Methods). Although the
ascertainment bias associated with inversion detection predicts
an enrichment of high-frequency inversions (~0.20 expected
MAF), the observed frequencies tend to be higher than expected
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in all population groups (Fig. 4a). When inversions are sepa-
rated by the generation mechanism, the increase in frequency is
significant only in NAHR inversions (Fig. 4a). We also investi-
gated how diverse genomic variables affect autosomal and chr. X
inversion frequencies. The most significant predictor is inver-
sion genetic length, which is negatively correlated with DAF of
NH inversions and explains 23–55% of the frequency variance in
the different population groups (Fig. 4b), followed by physical
length (19–54% variance explained). For NAHR inversions, only
5–14% of MAF variance is accounted by their genetic length,
whereas the ratio between IR and inversion length is positively
correlated with inversion frequency in all population groups and
explains 13–45% of MAF variance (Fig. 4c). This suggests that
the higher frequency of NAHR inversions might be related to
their repeated generation by recurrence.
Selection on human inversions. To investigate signals of natural
selection acting on specific inversions, we first measured inversion
frequency differences between populations using the fixation index
(FST), which can identify positive selection leading to a rapid
increase in allele frequency in some areas. The global FST value was
0.11 for autosomal inversions, 0.21 for chr. X inversions, and 0.73
for the one in chr. Y, with the largest frequency variation between
continents. Three inversions were within the top 1% of the FST
distributions derived from SNPs with the same frequency (Fig. 2;
Supplementary Data 7): HsInv0040, with frequency differences
between European populations, and HsInv0389 and HsInv0059,
with high frequency in Africa or East Asia, respectively. Eleven
more inversions fell within the top 5% of the empirical FST dis-
tribution, and were considered to have weak evidence of selection
(Fig. 2; Supplementary Data 7).
Second, we applied a novel test based on the frequency
spectrum of linked sites (LSFS), which is well suited to detect
deviations from neutrality in low-recombination regions, such
as inversions. We used optimized tests to identify positive and
long-term balancing selection maintaining a polymorphism
in several populations, and significance was assessed empiri-
cally using the null LSFS distribution from autosomes. Only 18
unique autosomal inversions with nearby perfect tag variants
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that could be reliably phased were analyzed, including most NH
inversions and HsInv0040 (Fig. 2; Supplementary Data 7). The
strongest signals (empirical test P < 0.01) were in HsInv0201 for
balancing selection and HsInv0006 and HsInv0031 for positive
selection. In addition, four other inversions showed weaker
evidence of balancing or positive selection. Consistent with the
FST results, in HsInv0006 and HsInv0059 positive selection was
detected in those populations with increased DAF (Fig. 2;
Supplementary Data 7).
As independent confirmation of balancing selection signatures,
we also used the recently developed non-central deviation
statistics, NCD1 and NCD2, which detect site frequency spectrum
shifts towards an equilibrium frequency and an excess of
polymorphic sites44. However, the results of these tests summar-
ize the data of all the SNPs in a region and are not necessarily
linked to the inversion, as before. Focusing on signals detected in
at least three populations, we found respectively four and six
inversions with strong and weak signatures of balancing selection
for NCD1 or NCD2 (Fig. 2; Supplementary Data 7). Many of
these candidates could not be analyzed with the LSFS method
because of the lack of tag SNPs or correspond to low-frequency
inversions, such as HsInv1051 and HsInv0209, that are unlikely
the targets of selection, but consistent results were found for
HsInv0201.
Effect of inversions on genes and gene expression. As previously
described, some of the analyzed inversions can have important
effects on genes4,9,21,25–28. Although half of our inversions (21/
45) are located in intergenic regions, three of them invert genes,
eight are located within introns, seven might exchange gene
sequences overlapping the IRs at the breakpoints, and six affect
genes more directly through the inversion or deletion of an
internal exon (HsInv0102, HsInv0201) and the disruption of the
whole gene (HsInv0340, HsInv0379, HsInv1051) or an alternative
transcript isoform (HsInv0124) (Fig. 2 and Supplementary
Table 3).
We measured the effect of the 42 autosomal and chr. X
inversions with MAF > 0.01 on expression of nearby genes (<1
Mb away) by linear regression between inversion genotypes and
LCL transcriptome data from the GEUVADIS consortium45. To
increase statistical power and reliability, the analysis was
replicated in two datasets: (1) 173 CEU, TSI and YRI individuals
with inversion genotypes; and (2) the complete GEUVADIS set of
445 European (358) and African (87) individuals in which the
genotypes of 33 inversions could be imputed accurately
(Supplementary Fig. 4A). Considering the largest sample size
for each inversion, we uncovered eight inversions significantly
associated with LCL expression of 27 genes and 44 transcripts
(Supplementary Fig. 4B; Supplementary Data 8), with highly
concordant results for those analyzed in both datasets (7/7 genes
and 11/12 transcript effects were replicated) (Supplementary
Fig. 4C). As negative control, no associations were observed by
permuting inversion genotypes relative to expression levels
(Supplementary Fig. 4D). Moreover, significant expression effects
were robust when applying different analysis approaches (see
Supplementary Fig. 4E-F and Supplementary Methods), and
inversions acting as expression quantitative trait loci (eQTLs)
located significantly closer to the transcription start site (TSS) of
the differentially expressed genes (<100 kb) (Supplementary
Fig. 4D).
Next, we examined inversion expression effects in other tissues
through variants already reported as eQTLs in the GTEx
project46. We found 62 genes with eQTLs in different tissues in
high LD (r2 ≥ 0.8) with 11 of the 26 analyzed inversions,
including seven not detected in LCL data (Supplementary Fig. 5;
Supplementary Data 9). By searching for eQTL signals in
moderate LD (r2 ≥ 0.6) with some of the recurrent inversions,
we found additional potential expression differences associated
with HsInv0124 and in the genes affected by HsInv0030, which
exchanges the first exon and promoter of chymotrypsinogen
precursor genes CTRB1 and CTRB2 expressed only in
pancreas21,25, and HsInv0340, which disrupts the long non-
coding gene LINC00395 expressed in testis (Supplementary Fig. 5;
Supplementary Data 9). In total, 17/27 of inversion-gene
associations in LCLs were also identified in the smaller GTEx
sample (Supplementary Fig. 5).
To assess if inversions were the main cause of the observed
expression changes, we performed a joint eQTL analysis in LCLs
including our inversions together with SNPs, indels and structural
variants from the 1000GP3,4. Two inversions, HsInv0124 and
HsInv1051, were the most likely causal variant for two genes and
three transcripts in LCLs (Fig. 5a). Six other inversions show the
highest LD (r2≥ 0.9) with variants reported as first or second lead
eQTL in a given tissue by the GTEx project (Supplementary
Fig. 6). Similarly, for recurrent inversions HsInv0124 and
HsInv0030, eQTL significance in GTEx data increases with LD
with the inversions, supporting their causal role (Fig. 5b). In
general, some of the strongest effects are related to inversions
affecting exonic sequences, although the consequences can be
complex and need to be investigated in detail. For example,
HsInv1051 breaks the CCDC144B gene and the apparent
upregulation of specific isoforms (Fig. 5a) is actually due to the
creation of a fusion transcript with new sequences at 3′ (Fig. 5c;
Supplementary Fig. 7). HsInv0124 is the lead variant for the
antisense RNAs RP11-326C3.7 and RP11-326C3.11, which over-
lap respectively the IFITM2 and IFITM3 genes located at the
breakpoints, and it has opposite effects in the two pairs of
overlapping transcripts (Supplementary Data 8; Supplementary
Data 9). Also, HsInv0102 removes the RHOH isoforms with the
alternative non-coding exon that gets inverted, but its effect is
masked by a more frequent lead eQTL (SNP rs7699141) acting in
the same direction. On the other hand, HsInv0058 is associated
with chr. 6 MHC haplotypes APD, COX, DBB, QBL and SSTO,
which extend ~4Mb and harbor important functional differ-
ences47, suggesting that other variants in these haplotypes are
responsible for the observed effects.
Inversions and phenotypic traits. The role of inversions in
phenotypic variation was investigated using available genome-
wide association studies (GWAS) data. We found a 1.26- and
1.95-fold increase in GWAS Catalog48 and GWASdb49 variants in
the inversion and flanking regions (±20 kb). The top inversion
driving this result was the MHC-inversion HsInv0058, but
HsInv0030 and HsInv0347 showed similar enrichment of GWAS
hits in both datasets (Fig. 5d; Supplementary Fig. 8A-B). GWAS
signals close to the latter two inversions are consistent with their
effect on genes, involving type 1 and 2 diabetes, pancreatic cancer,
insulin secretion, and cholesterol and triglyceride levels for
HsInv0030, and glaucoma and optic disc and nerve characteristics
for HsInv0347, which is associated to the expression of c14orf39
(SIX6OS1) and SIX6, related to eye development.
We also explored whether inversions were in strong LD (r2 ≥
0.8) with known GWAS hits in the population where the
association was reported. That is the case of HsInv0004, which is
in complete LD in Europeans with a nearly genome-wide
significant GWAS SNP related to asthma susceptibility in
children and another one associated with body mass index in
asthmatic children (Supplementary Table 4). Moreover,
HsInv0006 is linked to schizophrenia in Ashkenazi Jews and
glaucoma in Europeans (Supplementary Table 4). Remarkably,
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several of these inversions affect gene expression as well (Fig. 2).
A good example is HsInv0031, which is associated with lower
levels of FAM92B in cerebellum and is in almost perfect LD in
Europeans (r2= 0.98) with SNP rs2937145 associated with
Alzheimer’s disease risk (Fig. 5e; Supplementary Table 4).
Nevertheless, for many inversions the low LD with SNPs means
that any effects would be missed in typical array-based GWAS
(Supplementary Fig. 8C).
Discussion
This work represents the most exhaustive and accurate study of
human inversions so far, including a significant fraction of
common inversions19, and it is focused on inversions mediated by
IRs, which generally escape detection. New genome-wide tech-
niques are providing a more complete inversion catalogue13–18,
but they tend to be laborious and expensive, and population data
in well-characterized individuals are still scarce. In addition, in
many cases the high genotype error rate has precluded identifying
tag variants that could be used to infer inversion effects4,40. Thus,
the new genotyping method developed here and the reliable
information from multiple individuals of different populations
generated are crucial to fill the void in the knowledge of this type
of variation.
Despite the effort to include as many inversions as possible,
only those validated and with well-characterized breakpoints
could be analyzed19. In addition, important limitations exist for
the study of those mediated by IRs. Although it is not clear how
many of them are real, in the InvFEST database there are ~100
inversion predictions with 1–25 kb inverted segmental duplica-
tions (SDs) at the breakpoints, which could be potentially inter-
rogated using our method, and ~250 with larger SDs, which are
currently out of reach of the methodology19. Therefore, further
improvements and complementary strategies, such as the possi-
bility of making directed cuts in specific positions or estimating
the distance between regions separated by larger repeats, are
necessary to expand the range of analyzed inversions. Never-
theless, the present work already offers a good picture of the
contribution of common inversions to genetic diversity, adapta-
tion, and phenotypic traits in humans.
In particular, we found clearly contrasting patterns for inver-
sions generated by homologous and non-homologous mechan-
isms, supporting a high-degree of recurrence of all inversions
mediated by highly-identical IRs except three (two of which have
very low frequency). Recurrent inversions are characterized by
low LD with other variants, a large amount of shared SNPs and
shared haplotypes between O1 and O2 chromosomes (Fig. 3).
Also, recurrence is not limited to humans but extends to other
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great ape species. Similar results had been found in previous
small-scale studies21,24,26, but thanks to the analysis of many
more individuals and populations, multiple controls (such as
genotype confirmation by PCR of both breakpoints and different
sources of nucleotide variation data) and a detailed analysis of
haplotype relationships, we have obtained a better estimate of the
independent inversion events. Specifically, we found nine more
recurrence events in the five inversions originally predicted as
recurrent in humans and that seven inversions considered to be
unique or lacking information in CEU are recurrent as well21,26.
This suggests that, like other repeats, IRs are rearrangement
hotspots and the genome is more dynamic than previously
thought. However, recurrence has been detected only through the
sequences associated with the inversion, and we need more direct
ways to quantify inversion generation rates precisely.
As for other types of recurrent changes50,51, the lack of asso-
ciation between SNPs and many inversions and poor coverage by
common arrays (Supplementary Fig. 8C) means that their phe-
notypic effects have been largely missed in GWAS. For example,
half of the NAHR inversions cannot be accurately predicted with
typical imputation algorithms (Supplementary Fig. 4A). We have
found 23 and 22 inversions with different selection and functional
signatures, respectively (Fig. 2). More importantly, although not
all analyses could be applied to every inversion, there is a sig-
nificant enrichment of inversions with both effects on genes or
gene expression and selection signals directly linked to them
(Fisher’s exact test P= 0.0320) (see Supplementary Methods).
This combination of the two independent types of evidence
strongly indicates that inversions can have important con-
sequences in humans.
One particularly interesting example is HsInv0201, an old
inversion (>1.5 Mya) with intermediate frequency around the
globe and clear signals of balancing selection (Fig. 6a), which
deletes an exon of SPINK14 and is lead eQTL for two nearby
genes (Supplementary Data 9). Moreover, the inversion haplotype
is the main responsible for the lower SPINK6 expression during
immune response to Salmonella infection52,53 (Fig. 6b). In fact,
HsInv0201 eliminates the promoter and first exon of a putative
novel SPINK6 transcript (Fig. 6b) and it is in high LD (r2= 0.971
in EUR) with SNPs accounting for plasma levels of SPINK6
protein54. Together with the role of several of the affected genes
in lung and extracellular mucosas, this suggests that the inversion
could be related to immune response. In HsInv0006, its particular
distribution pattern and the selection test results point to positive
selection of the derived allele in Africa (Fig. 6a). Furthermore, the
inversion is located within DSTYK first intron21 and is associated
with expression changes in the proximal genes, including DSTYK
upregulation in different tissues (Fig. 6c; Supplementary Fig. 5).
DSTYK deletion causes pigmentation problems and elevated cell
death after ultraviolet irradiation55. Thus, positive selection on
these traits could explain the inversion increase in Africa. Inci-
dentally, the inverted orientation has been linked to higher risk of
glaucoma in Europeans (Supplementary Table 4) and glaucoma is
more common and severe in individuals from African ancestry56.
Other interesting candidates include HsInv0031, HsInv0059,
HsInv0124, HsInv0340, and HsInv0389 (Fig. 2).
Inversions differ from other genetic variants because of their
expected negative consequences in fertility resulting from the
generation of unbalanced gametes by recombination30,31, which
is exemplified by the reduction in frequency with genetic length
(Fig. 4b) and the small number of inversions described compared
to CNVs19. According to this, there could be a maximum length
for an inversion to behave neutrally in terms of its fertility effects.
Above that size, some type of compensatory selection, perhaps
related to advantageous regulatory changes on nearby genes,
would be necessary for the inversions to reach a certain
frequency. Therefore, this may explain the observed enrichment
of inversions with functional and selection signals. Future in-
depth studies of the identified candidates and other inversions
will help uncover their real role in human evolution and the
unexplained part of the genetic basis of complex traits.
Methods
Human and ape DNA samples. We used 550 human samples included in the last
phase of the HapMap Project and many of them in 1000GP phase 1 (Ph1) and 3
(Ph3)1–3, which belong to seven populations of four main population groups (AFR,
EUR, SAS, and EAS), plus individual NA15510 of unknown origin (see Supple-
mentary Table 1 and Supplementary Data 2 for details). Most individuals were
unrelated, but 70 are either children of mother-father-child trios (30 in YRI and 30
in CEU) or cryptic first and second-degree relatives (9 in LWK and 1 in GIH)2,3.
Genomic DNAs of 70 CEU and 10 YRI samples and NA15510 were extracted from
LCLs commercialized by the Coriell Cell Repository (Camden, NJ, USA), while the
rest of DNAs were acquired from Coriell21,26,28. Chimpanzee and gorilla DNAs
include six already used to genotype most of the inversions from frontal cortex
tissue samples of the Banc de Teixits Animals de Catalunya (N457/03, Z01/03 and
Z02/03) or LCLs from Barcelona Zoo individuals (PTR1211, PTR1213, and
PTR1215)21,26, plus 19 chimpanzee and five gorilla DNAs extracted from a
previously-existing collection of primate LCLs of one of the authors (Supple-
mentary Data 5). Ape samples comprise four mother-father-child trios and one
father-son pair in chimpanzees and one father-son pair in gorillas. As for humans,
cells were grown in 75-ml flasks to nearly confluency and high-molecular weight
genomic DNA was obtained using a standard phenol-chloroform extraction26. All
procedures that involved the use of human and non-human primate samples were
approved by the Animal and Human Experimentation Ethics Committee (CEEAH)
of the Universitat Autònoma de Barcelona.
Experimental genotyping of inversions. Initial genotypes for 41 inversions were
obtained by newly developed assays based on the MLPA technique (Supplementary
Data 1), which has been widely used for genome copy-number analysis and consists
on the multiplex amplification of fragments of different sizes with common primers
that are fluorescently labeled, and their detection by capillary electrophoresis42.
Most NH inversions (17) were genotyped simultaneously from 100–150 ng of DNA
with a slightly modified MLPA protocol using two pairs of probes that bind spe-
cifically at the breakpoint sequences of each orientation (AB and CD or AC and
BD), with one of the probes that could be common to both pairs (Fig. 1). For 24
inversions with IRs or other repetitive sequences at the breakpoints, we developed a
new iMLPA method that uses a combination of iPCR and MLPA. iMLPA requires
some extra processing of the DNA with a restriction enzyme that cuts at each side of
the breakpoint repetitive sequences, followed by self-circularization of all the
digested DNA molecules together by ligation in diluted conditions with T4 DNA
ligase and DNA purification. Then, MLPA was carried out as usual with a pair of
probes that bind specifically at the self-ligation site of the circular molecules from
each orientation (see Supplementary Methods for MLPA and iMLPA details).
Supplementary Data 10 lists the sequences and concentrations of the probes used
for MLPA (68) and iMLPA (87).
PCRs and iPCRs were carried out to genotype seven inversions in the 551
human samples (including four not analyzed in the MLPA/iMLPA assays) and to
validate many of the MLPA/iMLPA genotypes (Fig. 1; Supplementary Data 1).
Multiplex PCRs and iPCRs of each inversion were done with primers flanking
either the breakpoint (PCR) or the self-ligation site of circularized molecules
(iPCR) from the two orientations21,26 (Supplementary Data 11). For the restriction
site polymorphism analysis, we downloaded dbSNP (version 142) SNPs and indels
around the inversion region (±50 kb) and determined all possible restriction site
gains or losses affecting the iPCR/iMLPA experiments. To ensure that the
genotypes were completely accurate, in most potential discrepancies both
breakpoints of each orientation were tested.
For inversion genotyping in chimpanzees and gorillas, first we ran the same
MLPA and iMLPA assays as described above, and those inversions that did not
work were genotyped by PCR or iPCR. In some cases, new chimpanzee or gorilla
specific primers and restriction enzymes for iPCR were used to overcome human
assay problems26 (Supplementary Data 5; Supplementary Data 11). However, this
was not always possible due mainly to deletions or genome gaps, and a few
inversions in one or both species could not be tested. All polymorphic inversions in
chimpanzees or gorillas were validated by PCR or iPCR of at least one breakpoint
to make sure that there were no errors in the iMLPA results.
Analysis of nucleotide variants associated with inversions. We measured
pairwise LD (r2) between inversions and overlapping and neighboring biallelic
variants up to 200 kb at each side of the inversion from 1000GP Ph3 (including
SNPs and indels for 434 unrelated individuals) and HapMap release 27 (including
fewer SNPs but all the 480 unrelated individuals) using either plink v1.9057 or
Haploview v4.158. Variants located within the breakpoint interval and associated
deletions or IRs were excluded for this and subsequent analysis to avoid possible
genotyping errors. Supplementary Data 12 lists the inversion tag variants with r2 ≥
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0.8 from 1000GP and HapMap data considering all the individuals together, as well
as each population and population group. This analysis allowed us to detect a few
inversion genotypes that did not match those expected from the tag variants and
most of them were confirmed to be genotyping errors by independent PCR or iPCR
validation (Supplementary Fig. 2). SNPs and indels around inversion regions were
further classified directly from the genotype data according to its distribution
across orientations in fixed (r2= 1), shared (unambiguously polymorphic in both
orientations) and polymorphic in O1 or O2 chromosomes using in-house perl and
bash scripts21,26. To minimize possible genotyping errors, only the most reliable
variants according to the 1000GP strict accessibility mask were included. Non-
recombining flanking regions were defined from the 1000GP data (which has more
resolution than HapMap) as the longest sequence outside the breakpoints up to a
maximum distance of 20 kb that: (1) does not contain reliable shared variants
compatible with a crossing-over event between orientations; and (2) includes most
of the fixed variants (Supplementary Table 2).
Phasing and visualization of haplotypes. Each orientation haplotypes were
determined following two complementary strategies to minimize errors and obtain
more robust results. First, after testing several commonly-used phasing programs,
we selected PHASE 2.159 because it avoids switch errors in inversion heterozygotes
by fixing the phase of the two orientation alleles added at the breakpoint
positions21,26. Phasing was done independently for the YRI, LWK, EUR, SAS, and
EAS populations or population groups, using the available trio information when
possible and five iterations (−x5) for HapMap data and two iterations (−x2) with
the hybrid model (−MQ) for 1000GP data. Only variants within the inverted
region plus 20 kb of flanking sequence for 1000GP Ph1 data (which was the only
one available at that time) or 200 kb for HapMap data were selected. Second, we
took advantage of the 1000GP Ph3 phased haplotypes3 to impute directly the
inversion orientation based on the presence of perfect tag variants (r2= 1). For
inversions without perfect tag variants, only homozygotes or hemizygotes for each
orientation, in which the inversion status of the haplotypes can be assigned
unambiguously, were analyzed.
The relationships between the different haplotypes of each dataset were
visualized by combining several data sources and representation methods. Phased
1000GP Ph1 and HapMap haplotypes were used to build Median-Joining (MJ)
networks60 with the NETWORK v.4.6.1.3 software (www.fluxus-engineering.com).
In addition, we devised our own representation of the haplotype relationships and
the distribution of nucleotide changes along the sequence, named integrated
haplotype plot (iHPlot), which combines a hierarchical clustering, distance matrix
and visual alignment of the alleles in each polymorphic position, plus the haplotype
orientation and the populations in which it is present (see Supplementary Methods
for details).
Inversion origin was estimated from the information of the different phasing
and haplotype visualization strategies, which overall showed consistent results
(see Supplementary Methods). For inversions with perfect tag variants, the analysis
was based mainly on 1000GP Ph3 haplotypes (including when possible the flanking
non-recombining region), which allowed a better discrimination of haplotypes,
filtering of accessible SNPs according to the pilot accessibility mask and had less
phasing errors due to the use of sequences from more individuals3. For inversions
without tag variants, we relied mainly in the phased 1000GP Ph1 haplotypes
iHPlots, since all the genotyped individuals in common could be analyzed.
Inversion recurrence events were conservatively estimated by identifying clusters of
haplotypes with both orientations that differ significantly from all others with the
same orientation as the potential recurrence event, after eliminating possible
phasing errors in inversion heterozygotes (see Supplementary Methods). Around
1–25 individuals supporting each of the independent recurrence events were
validated by PCR or iPCR (in this case testing mostly both breakpoints) to discard
possible inversion genotyping errors (Supplementary Data 3). Also, we validated
the genotype of many more individuals with unexpected orientation-haplotype
combinations and of other inversions with a high proportion of shared SNPs for
which recurrence events could not be clearly identified. HsInv0832 inversion rate
was estimated from the publicly available information of 232 of the 282 genotyped
males (Supplementary Data 4) by calculating the total number of mutations and
generations along the genealogical tree of the analyzed Y chromosomes using the
approach of Repping et al.61 and Hallast et al.62 (see Supplementary Methods).
Ancestral orientation and inversion age estimate. Besides the experimental
analysis in chimpanzees and gorillas, the ancestral state of inversions was com-
plemented by bioinformatic and manual inspection of four of the best non-human
primate genome assemblies (see Supplementary Methods). Due to their fragmented
status, the orientation of several available ancient hominin genomes (Supple-
mentary Data 6) was determined by identifying the reads that span the O1 or O2
breakpoints of 19 NH inversions without IRs using a library with four 100-bp
sequences centered at the two breakpoints of both orientations (Supplementary
Data 13) and a slightly modified version of the BreakSeq pipeline21,27,28.
Age of unique inversions was obtained with the usual divergence-based
approach63,64, using the pairwise differences between orientations from all SNPs
(excluding indels) in the available 1000GP Ph3 haplotypes and the largest of the
two average pairwise differences within O1 or O2 sequences. To have more
information in short inversions, we considered the inverted region and any extra
non-recombining flanking region (up to 20 kb), excluding breakpoint intervals and
associated IRs or indels to avoid sequence errors. Confidence intervals of age
estimates were calculated by bootstrap sampling the same number of total
individuals with replacement 1000 times and using both a constant substitution
rate and two local substitution rates from the divergence with chimpanzee and
gorilla (see Supplementary Methods).
Inversion frequency analyses. To control the effect of the study design ascer-
tainment bias in the observed frequency of inversions, we simulated the detection
and genotyping process in biallelic SNPs from 1000GP Ph3. The process was
simulated in two steps: (1) selection of those SNPs for which the alternative allele is
present in 1000GP individuals matching the demographic and gender composition
of the detection panel (nine individuals for 38 autosomal or chr. X inversions
detected from the fosmid PEM data12 and one individual for six inversions
detected exclusively from the genome assembly comparison10); and (2) for each of
the PEM inversions, generate a random sample of 10,000 SNPs from the total pool
of polymorphic SNPs in the PEM panel according to the simulated detection
probability calculated from the SNP frequency and the inversion characteristics
(see Supplementary Methods). Mean and median frequencies of inversions and
SNPs in the 434 1000GP Ph3 individuals were compared by sampling 10,000 sets of
SNPs without replacement, with one matched-SNP per inversion at a time, and
empirical P-values were estimated as twice the fraction of samples with values more
extreme or equal than the observed.
Different genomic variables were tested to determine their effect on inversion
frequency: (1) physical length of the inverted region; (2) inversion genetic length;
(3) number of genes within the inversion or breakpoint regions; (4) distance to the
closest coding gene; (5) number of mammalian constrained sites inside the
inversion;65 (6) direct functional effect of inversions on genes (Supplementary
Table 3); and (7) size of breakpoint IRs. Inversion genetic length was estimated as
the cumulative 4Ner for all the genotyped chromosomes using the 1000GP Ph3
SNP data and the LDhat v2.2 rhomap function66. Due to high correlation between
several variables, to keep only those with significant regression coefficients and
reduce the effect of potential outliers in reduced samples, we built robust regression
models of the autosomal and chr. X inversion frequency in each population group
by stepwise forward selection of predictors with the lmrob function from
robustbase R package67.
Inversion selection tests. Frequency differences between populations were cal-
culated with vcftools (v0.1.15) using the FST statistic68. FST values were compared
with empirical null distributions in the same individuals obtained from bialellic
SNPs accessible according to the strict mask, with a defined ancestral allele, and
that have similar frequency and chromosome type (autosome or chr. X) as the
inversion (see Supplementary Methods).
LSFS tests are a newly developed family of neutrality tests especially appropriate
for inversions, which are a direct application of nearly optimal linear tests for
neutrality69. The summary statistic was the frequency spectrum of variants closely
linked to the inversion, including their linkage pattern (nested or disjoint) with the
inverted allele70, and we tested strong positive or balancing selection coefficients.
LSFS was calculated from biallelic 1000GP Ph3 SNPs in the genotyped individuals,
after removing those with a GERP score65 higher than 2 and within 0.5 Mb of any
of the inversions in our dataset. Only 18 autosomal inversions unambiguously
phased into the 1000GP Ph3 haplotypes with perfect tag SNPs within 20 kb from
the breakpoints were analyzed using 3 kb non-overlapping windows localized
within the inverted or non-recombining flanking regions (skipping the
breakpoints, IRs and indels to avoid genotype errors). Inversion windows were
compared against the empirical LSFS computed around all autosomal SNPs and
tests were conditioned on the inversion frequency in the different populations.
Each population and window was tested separately and population P values of the
same windows were combined via Edgington’s method71, whereas the results
across different windows of an inversion were combined using a conservative and
an approximate approach (see Supplementary Methods).
NCD1 and NCD2 statistics44 to test long-term balancing selection acting on
autosomal and chr. X inversion regions were computed for three target frequencies
(0.3, 0.4, and 0.5) in overlapping windows of 2 kb (with 1 kb step), defined with the
same criteria as in the LSFS test, using 1000GP Ph3 SNPs (accessible according to
the pilot mask) from all individuals of the seven studied populations. Only
windows with a minimum of eight informative sites (either human polymorphisms
or fixed differences with chimpanzee in NCD2 only) and at least 16.7% of positions
covered by hg19-panTro4 alignments were considered. Finally, an empirical P-
value was assigned for each inversion region and population by comparing the tests
results with a null genome-wide distribution obtained by sampling regions of the
same size as the inversion (see Supplementary Methods).
Gene-expression analysis in LCLs. We analyzed 42 inversions (excluding two
with MAF < 1% and HsInv0832 in chr. Y) in 173 experimentally genotyped indi-
viduals (42 CEU, 84 TSI, and 47 YRI) with GEUVADIS45 and 1000GP Ph33 data.
Besides, we imputed 33 inversions in the complete set of 445 GEUVADIS indi-
viduals in common with 1000GP Ph3 (89 CEU, 91 TSI, 86 GBR, 92 FIN, and 87
YRI) using the already identified perfect tag SNPs (r2= 1) (19 inversions) or
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IMPUTE v2.3.272 (14 inversions with >90% average imputation accuracy) (Sup-
plementary Fig. 4A). LCL raw RNA-Seq reads (ArrayExpress experiment E-GEUV-
1) were aligned against the GRCh38.p10 human genome with STAR v2.4.2a73
using GENCODE version 26 annotations74. Gene-expression levels were estimated
as reads per kilobase per million mapped reads (RPKM) and transcript expression
levels were quantified with RSEM v1.2.3175. cis-eQTL analysis was done through
linear regressions implemented in QTLtools v1.176, considering 850 genes and
3318 transcripts expressed in at least 20% of the samples and with TSS within 1 Mb
from inversions. First, we carried out a targeted study to test only the association
with the genotypes of each inversion. Second, we performed a joint eQTL analysis
with inversions and neighboring 1000GP variants to estimate their contribution to
observed gene-expression changes and identify lead eQTLs. Expression values were
adjusted by gender, the first three principal components from 1000GP data (cor-
responding to continent, population and population structure) and a set of
expression principal components to capture technical confounding factors (for
genes and transcripts, respectively, 10 and 20 in the experimental dataset and 35
and 50 in the imputed dataset) (see Supplementary Methods). Next, they were
transformed to match normal distributions N(0,1) to avoid false positive associa-
tions due to outliers and significance was established at 5% false discovery
rate (FDR).
Inversions as eQTLs in other tissues and conditions. Gene-expression effects in
other tissues for 26 inversions were examined by looking whether their highest
associated SNPs across all populations (r2 ≥ 0.8) have been identified as cis-eQTLs
in different human tissues by the GTEx project (GTEx Analysis Release v7)46. Also,
we extended the analysis to seven recurrent inversions with SNPs in moderate LD
(r2≥ 0.6). To determine the potential causal variants, we checked if those SNPs in
highest LD with the inversions were reported as being the first or second lead eQTL
in a specific tissue. The same strategy was applied to link inversions to immune
eQTLs associated to the transcriptional response to Listeria and Salmonella of
primary macrophages from African-American (n= 76) and European-American
(n= 99) individuals52 and of macrophages differentiated from 123 induced plur-
ipotent stem cell (iPSC) lines of European origin to Salmonella plus interferon γ
stimulation53.
Association of inversions with GWAS SNPs. Association of inversions with
specific traits or diseases was based on the NHGRI Catalog of published GWAS
(release 2017-07-17)48 and the GWASdb (release 2015-08-19)49 databases. To
remove redundant entries, the strongest signal per locus (±100 kb genomic region)
was selected. Only inversions in high LD (r2 ≥ 0.8) with a GWAS signal in the
studied population or the closest one available were considered (Supplementary
Table 4). To investigate if the number of GWAS signals in the inversion and
flanking regions (±20 kb) was higher than expected by chance, we crossed GWAS
Catalog and GWASdb signals with 1000GP variants and grouped together those in
high LD (r2 ≥ 0.8) and associated to the same phenotype. Enrichment P values were
calculated by comparison with a null distribution from 1000 random genomic
regions as a background model for each inversion, controlling by inversion size and
SNP frequencies (average SNP frequency ±0.01 and Chi-square test P > 0.05 for the
number of SNPs with MAF <0.2 and ≥0.2 compared to the inversion region) and
excluding gaps and chr. Y. To test the enrichment in specific inversions, we
repeated the same analysis computing a one-tailed empirical P-value for each
inversion.
Statistical information. Details of the statistical tests are described in the corre-
sponding sections. In many cases P-values were derived from empirical genome-
wide null distributions from at least 1000 random samples and two-tailed tests
were always used, except when specifically mentioned.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data described in this article are available in the Supplementary Information and in
the InvFEST database (http://invfestdb.uab.cat/). In addition, inversion genotypes have
been deposited in the dbVar database (https://www.ncbi.nlm.nih.gov/dbvar/) under
accession number nstd169 [https://www.ncbi.nlm.nih.gov/dbvar/studies/nstd169/]. The
source data underlying Figs. 2, 3a-c, 4a-c, 5a, c, e and 6a-b and Supplementary Figs. 1, 2a-
b, 4a, f, 5 and 8a-c are provided as a Source Data file. All other relevant data are available
upon request.
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